Tuesday, March 24, 2026

I am a long term investor and trade seldom, it took me a while to learn that but it has served me well Here are some thoughts drafted by Claude for me

 GTC 2026, Vera Rubin, and the AI Infrastructure Investment Thesis

The Paradox: A Spectacular Show, A Flat Stock

I hold NVDA. Have for a while. My oldest position is from 2016, (now about a 12,000% gain) accounts in part for why I can live so well in retirement.  So I watched GTC 2026 with the particular attention of someone with skin in the game — and what I witnessed was genuinely impressive by almost any measure. Jensen Huang took the stage at the SAP Center in San Jose, played to a packed house of more than 30,000 developers, and proceeded to announce that combined Blackwell and Vera Rubin purchase orders are now projected to reach $1 trillion through 2027 — up from the $500 billion figure he cited at the same event a year ago. CNBC

And NVDA? The stock dropped roughly 2% over the five days surrounding the conference. TipRanks

This is a pattern worth understanding, not panicking about. It's the kind of thing that separates investors from traders. Early on I fancied myself a trader, my embrace of investing has been way more successful.


What Vera Rubin Actually Is

The Vera Rubin platform isn't a single chip — it's a full-stack AI supercomputer. It brings together seven new chips: the Vera CPU, Rubin GPU, NVLink 6 Switch, ConnectX-9 SuperNIC, BlueField-4 DPU, Spectrum-6 Ethernet switch, and the newly integrated Groq 3 LPU — all designed to operate as one cohesive system powering every phase of AI, from massive pretraining through agentic inference. NVIDIA Newsroom

The efficiency story is the headline number: NVL72 GPU racks deliver 10x higher inference throughput per watt at one-tenth the cost per token compared to the prior Blackwell platform. DataCenterKnowledge That's not an incremental improvement. That's the kind of performance-per-watt leap that unlocks entirely new deployment economics for enterprise AI.

The Groq 3 LPX racks — Nvidia's first product following its $20 billion Groq acquisition in December — are designed to handle low-latency, large-context agentic inference DataCenterKnowledge, the workload type that will dominate as AI moves from answering questions to actually doing things. When paired with Rubin NVL72, the combined system can reportedly boost throughput per watt by 35x for these workloads.

Looking further out, Huang previewed Feynman, Nvidia's next major architecture after Rubin, which pairs a new CPU called Rosa — named for Rosalind Franklin — with LP40, Nvidia's next-generation LPU, and an updated networking stack. NVIDIA Blog The platform roadmap is now extending to the end of the decade.


Why the Stock Didn't Pop

Deepwater Asset Management's Gene Munster put it plainly: "Jensen's keynote reinforced a simple point — demand is tracking well above even high expectations, while investors remain concerned that growth beyond 2027 could slow sharply or even decline." Benzinga

That's the wall of worry in a sentence. The announcements weren't bad; they were largely anticipated. TD Cowen analyst Joshua Buchalter noted that Nvidia's $4.4 trillion+ market cap and recent gains have contributed to a flat, range-bound pattern even as strong results roll in. TipRanks When expectations are priced in at that scale, even good news gets a muted response. Shares actually surged over 4% during Huang's presentation before paring gains in a classic sell-the-news move. Quiver Quantitative

This also follows an established pattern: after the October 2025 GTC, the stock dropped 2% the next day. TipRanks This isn't news — it's reflexive short-term behavior around an event that the market had already partly priced.


The Bull Case Remains Intact

Wall Street hasn't flinched. Goldman Sachs reiterated its $250 price target and maintained a buy rating, with analyst forecasts projecting NVDA revenue of $393 billion for fiscal year 2027 and $521 billion for 2028 — at a forward P/E compressing to 14.9x by 2028. TheStreet That's cheap for a company growing at those rates.

Bank of America's Vivek Arya maintained a $300 price target, arguing the widely-cited $1 trillion data center figure actually understates the opportunity because it doesn't account for CPUs, STX storage racks, and LPX LPU racks. FinancialContent The TAM is bigger than the headline number.

Wedbush's Dan Ives, one of the more consistently correct voices on Nvidia over the past three years, called the keynote a "confidence boost" and said Nvidia remains "two to three years ahead of anyone, including Google" — adding, "it's their world; everyone else is paying rent." TheStreet


My Take as a Long-Term Holder

I'm not a trader, and GTC week volatility doesn't change my thesis. The thesis is simple: the world is going to spend enormous sums building AI infrastructure for the next decade, and Nvidia has constructed — through CUDA, through its full-stack integration, through years of ecosystem lock-in — a position that is extremely difficult to dislodge. Big Tech companies including Alphabet, Amazon, Meta, and Microsoft are projected to invest a combined $650 billion in AI infrastructure during 2026 alone, up 58% from $410 billion in 2025. Intellectia.AI Most of that compute runs on Nvidia.

The Vera Rubin platform is meaningful not just as a product, but as a signal: Nvidia is methodically expanding from GPUs into CPUs, networking, inference accelerators, and now even space computing. Munster's Deepwater estimates that the automotive and robotics segment could grow from $2.3 billion last year to more than $70 billion by calendar year 2030. Benzinga That's not priced in today's share price.

At roughly 17% off its all-time high, NVDA is actually sitting at an attractive entry point for anyone with a multi-year horizon. The Motley Fool For holders like me, the post-GTC dip is noise — not signal.

The infrastructure buildout Jensen Huang is describing isn't hype. I've been in computing since 1969. I've watched hype cycles come and go. I have also endured 50+% drawdowns in Nvidia before. What's different here is the demand is real, the orders are confirmed, and the roadmap is the most technically credible I've seen in this industry since the early days of cloud. Vera Rubin isn't a PowerPoint slide; it's in production and shipping to hyperscalers this year.

I'll hold.

Sources:

The Logic of Longevity: A Mechanistic Approach to My Supplement Regimen (AI Gemini generated based on my current routine)

 

Overview

This post outlines the evidence-based rationale for my current longevity stack. Rather than following trends, this selection is based on targeting specific cellular pathways—primarily mTOR, AMPK, and mitochondrial efficiency—to maintain muscle mass and cognitive clarity at 76.


I. Muscle Protein Synthesis and Preservation

Maintaining lean muscle mass (sarcopenia prevention) is the highest priority for longevity.

  • HMB (Hydroxymethylbutyrate): A metabolite of leucine that aids in slowing muscle protein breakdown.

  • Creatine (10g daily): Beyond ATP recycling for physical power, 10g is a robust dose that supports cognitive processing speed and neuroprotection.

  • Whey Protein & Beta-Alanine: Used synergistically to provide the substrate for repair and to buffer intramuscular acidity during exertion.

II. Metabolic Regulation and Glycemic Control

Stable blood glucose and insulin sensitivity are the primary predictors of healthspan.

  • Berberine: Often referred to as a "natural metformin," it activates the AMPK pathway, improving glucose metabolism and mitochondrial biogenesis.

  • Psyllium Fiber: A foundational prebiotic that blunts postprandial glucose spikes and supports the microbiome-brain axis.

III. Cognitive and Mitochondrial Support

To maintain the processing standards required for complex Python development and financial analysis, mitochondrial health is non-negotiable.

  • Magnesium Threonate: Selected specifically for its ability to cross the blood-brain barrier effectively to support synaptic plasticity.

  • CoQ10 & Cordyceps: These work at the cellular level to optimize the electron transport chain (ETC) within the mitochondria, increasing cellular energy (ATP) production.

  • Glycine: An inhibitory neurotransmitter that also serves as a precursor to glutathione, the body’s master antioxidant.

  • Shutterstock
    Explore

IV. Data Integration: Fitbit and Wyze

Evidence-based health is a closed-loop system. I monitor the efficacy of this stack via:

  1. Resting Heart Rate (RHR) & HRV: Tracking the autonomic nervous system's response to the Cordyceps and CoQ10.

  2. Sleep Architecture: Using Magnesium and Glycine to optimize Deep and REM sleep stages, verified via Fitbit telemetry.

  3. Body Composition: Monitoring the HMB/Creatine/Whey efficacy through Wyze scale trends to ensure weight remains "high-quality" mass.


V. Clinical References & Sources

. the list:

  • Colostrum 1000mg 2xDay

    Fish oil 1,000 3 x day

    Q10 300mg

    B-12 5,000 micrograms

    Tumeric 1000mg

    Magnesium citrate 250 1xday

    Magnesium l-threonate 2 at night 

    Fiber 5 3xday

    Glycine 1000 mg 3x day

    HMB 1000mg 3x day

    Cordyceps 3 capsules day

    Berberine 3 cap/ day

    Beta-alanine 2 caps/day

    Creatine 10 g day 

    Whey protein/ isopure

    Glucosamine/ Chondroitin 2/ day


Saturday, February 9, 2008

Testing 1

Here is a 1st post.